[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Page 95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31273]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: 
    The companies listed below applied to be registered as importers of 
various basic classes of controlled substances. Information on 
previously published notices is listed in the table below. No comments 
or objections were submitted and no requests for hearing were submitted 
for these notices.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR docket                          Published
----------------------------------------------------------------------------------------------------------------
Rhodes Technologies......................  81 FR 46956.................  July 19, 2016.
Bellwyck Clinical Services...............  81 FR 54603.................  August 16, 2016.
Cerilliant Corporation...................  81 FR 57933.................  August 24, 2016.
Noramco, Inc.............................  81 FR 57932.................  August 24, 2016.
Cody Laboratories, Inc...................  81 FR 54602.................  August 16, 2016.
AMRI Rensselaer, Inc.....................  81 FR 54603.................  August 16, 2016.
ALMAC Clinical Services Incorp (ACSI)....  81 FR 54602.................  August 16, 2016.
Fresenius Kabi USA, LLC..................  81 FR 54601.................  August 16, 2016.
Akorn, Inc...............................  81 FR 57935.................  August 24, 2016.
Actavis Laboratories FL, Inc.............  81 FR 54602.................  August 16, 2016.
Unither Manufacturing LLC................  81 FR 61250.................  September 6, 2016.
Cambrex Charles City.....................  81 FR 63222.................  September 14, 2016.
United States Pharmacopeial Convention...  81 FR 63220.................  September 14, 2016.
R & D Systems, Inc.......................  81 FR 64509.................  September 20, 2016.
Catalent CTS, LLC........................  81 FR 66081.................  September 26, 2016.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each company's 
maintenance of effective controls against diversion by inspecting and 
testing each company's physical security systems, verifying each 
company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]
 BILLING CODE 4410-09-P